Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1

American Journal of Physiology - Renal Physiology - Tập 281 Số 3 - Trang F454-F468 - 2001
Petra Arndt1, Christopher Volk1, Valentin Gorboulev1, Thomas Budiman2, Christian Popp1, I Ulzheimer-Teuber1, Aida Akhoundova1, Stefan Koppatz1, Ernst Bamberg2, Georg Nagel2, Hermann Koepsell1
1Institute of Anatomy of the Bayerische Julius-Maximilians-Universität, 97070 Würzburg; and
2Max-Planck-Institute of Biophysics, 60596 Frankfurt, Germany

Tóm tắt

The rat organic cation transporter (rOCT)-2 was characterized by electrical and tracer flux measurements compared with rOCT1. By applying choline gradients to voltage-clamped Xenopus oocytes expressing rOCT2, potential-dependent currents could be induced in both directions. Tracer flux measurements with seven organic cations revealed similar Michaelis-Menten constant values for both transporters, with the exception of guanidine. In parallel experiments with rOCT2 and rOCT1, inhibition of tetraethylammonium transport by 12 cations, 2 weak bases, corticosterone, and the anions para-amminohippurate, α-ketoglutarate, and probenecid was characterized. The IC50values of many inhibitors were similar for both transporters, whereas others were significantly different. Mepiperphenidol and O-methylisoprenaline showed an ∼70-fold lower and corticosterone a 38-fold higher affinity for rOCT2. With the use of these inhibitors together with previous information on cation transporters, experimental protocols are proposed to dissect out the individual contributions of rOCT2 and rOCT1 in intact proximal tubule preparations. Inhibition experiments at different pH levels strongly suggest that the weak base quinine passively permeates the plasma membrane at physiological pH and inhibits rOCT2 from the intracellular side.

Từ khóa


Tài liệu tham khảo

10.1074/jbc.M004645200

10.1152/ajprenal.2000.278.6.F853

10.1124/mol.54.2.342

10.1074/jbc.271.51.32599

10.1016/0304-4157(95)00006-D

10.1089/dna.1997.16.871

10.1124/mol.56.6.1254

10.1074/jbc.272.16.10408

10.1038/372549a0

10.1074/jbc.273.47.30915

10.1124/mol.56.1.1

Hofstee BHF, 1955, Enzymologia, 17, 273

Hohage H, 1994, J Pharmacol Exp Ther, 268, 897

10.1152/ajprenal.1988.254.1.F56

10.1152/ajprenal.2000.279.4.F679

10.1074/jbc.273.26.15971

10.1146/annurev.physiol.60.1.243

10.1007/s002329900475

Mehrens T, 2000, J Am Soc Nephrol, 11, 1216, 10.1681/ASN.V1171216

10.1006/bbrc.1998.9034

10.1007/s003359900976

10.1074/jbc.272.51.31953

10.1038/clpt.1986.216

10.1006/bbrc.1996.1056

10.1016/S0005-2736(99)00005-X

10.1093/toxsci/47.2.181

10.1007/s003359900223

Sugawara-Yokoo M, 2000, Histochem Cell Biol, 114, 175, 10.1007/s004180000186

10.1152/ajprenal.1999.277.6.F890

10.1016/S0005-2736(97)00207-1

10.1016/0006-2952(77)90379-3

Ullrich KJ, 1993, Pflügers Arch, 425, 300, 10.1007/BF00374180

10.1007/BF00374179

Urakami Y, 1998, J Pharmacol Exp Ther, 287, 800

Van Montfoort JE, 2001, J Pharmacol Exp Ther, 298, 110

Veyhl M, 1993, J Biol Chem, 268, 25041, 10.1016/S0021-9258(19)74569-4

10.1016/S0005-2736(00)00189-9

10.1152/ajprenal.2000.279.3.F449

Wu X, 1999, J Pharmacol Exp Ther, 290, 1482

10.1074/jbc.273.49.32776

10.1124/mol.51.6.913